Healthcare, Regulatory and Reimbursement Landscape - Singapore

GlobalData, March 2012, Pages: 153

Healthcare, Regulatory and Reimbursement Landscape - Singapore

Summary

GlobalData, the industry analysis specialist, has released its report, “Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare market of Singapore. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Singapore. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Our team of industry experts.

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape of Singapore. The scope includes -
- Overview of the pharmaceutical and medical devices market of Singapore including the market size, market segmentation, key drivers and barriers for the market.
- Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
- Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and market authorization process for new drug and medical devices for Singapore.
- A detailed analysis of the political and economic environment of Singapore including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that exist in the healthcare market of Singapore.

Reasons to buy

The report on Singapore comprehensively covers both the pharmaceutical and the medical devices market of Singapore. The report will enhance your decision making capability. It will allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market of Singapore.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the Singapore healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Singapore.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of The Pharmaceutical Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Supply Channels
3.1.3 Market Segments
3.1.4 Major Players
3.2 Market Drivers and Barriers
3.2.1 Drivers
3.2.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Overview of Insurance Providers
4.1.3 Reimbursement Process
4.1.4 Patient Share in Healthcare Spending
4.1.5 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 New Drug Approval Process
4.2.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.4 Licensing Process for Pharmaceutical Exports and Imports
4.2.5 Intellectual Property Rights
4.2.6 Clinical Trial Regulations
4.2.7 Pharmaceutical Advertising Regulations
4.2.8 Pharmacy Regulations
4.2.9 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Structural Balance
5.3.9 Government Net Debt
5.3.10 Major Industries
5.4 Demography
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Share of Public and Private Sectors
5.6.4 Spending in Pharmaceutical R&D
5.7 Trade Associations
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Methodology
7.2.1 Coverage
7.2.2 Secondary Research
7.2.3 Forecasting
7.2.4 Primary Research
7.2.5 Expert Panel Validation
7.3 Contact Us
7.4 Bibliography
7.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceutical Market ($m), Singapore, 2005–2011
Table 2: Pharmaceutical Market ($m), Singapore, Forecast, 2011–2020
Table 3: Drugs Going Off-Patent, Revenues ($bn), Global, 2011–2012
Table 4: Major Pharmaceutical Companies, Singapore, Revenue ($m), 2010
Table 5: Major Products, Luye Pharma, 2011
Table 6: Major Products, Eu Yan Sang, 2011
Table 7: Major Products, Haw Par, 2011
Table 8: Overview of Healthcare Insurance System, Singapore, 2007–2009
Table 9: Healthcare Spending, Singapore, Patient Share (%), 2005–2010
Table 10: Format of Registration Dossier, Singapore, 2011
Table 11: Stages of Evaluation Process, Singapore, 2011
Table 12: Medical Devices, Classification, Singapore, 2011
Table 13: Patent Co-operation Treaty (PCT), International Application Process, Singapore, 2011
Table 14: Clinical Trial Certificates, Singapore, 2005–2010
Table 15: Clinical Trials by Therapeutic Areas (%), Singapore, 2010
Table 16: Target Processing Timelines of Clinical Trial, Singapore, 2010
Table 17: Labeling Requirements, Singapore, 2011
Table 18: GDP Per Capita ($), Singapore, 2005–2010
Table 19: GDP Per Capita ($), Singapore, Forecast, 2011–2020
Table 20: GDP, Singapore, Annual Growth (%), 2005–2010
Table 21: GDP, Singapore, Annual Growth (%), Forecast, 2011–2020
Table 22: GNI Per Capita ($), Singapore, 2005–2010
Table 23: Average Consumer Price Index, Singapore, 2005–2010
Table 24: Average Consumer Price Index, Singapore, Forecast, 2011–2020
Table 25: Average Consumer Price, Singapore, Annual Change (%), 2005–2010
Table 26: Average Consumer Price, Singapore, Annual Change (%), Forecast, 2011–2020
Table 27: Currency Exchange Rate (SGD/$), Singapore, 2005–2010
Table 28: Foreign Direct Investment ($bn), Singapore, 2005–2010
Table 29: Foreign Exchange Reserves ($bn), Singapore, 2005–2010
Table 30: Trade Balance ($bn), Singapore, 2005–2010
Table 31: Imports of Goods and Services ($bn), Singapore, 2005–2010
Table 32: Exports of Goods and Services ($bn), Singapore, 2005–2010
Table 33: General Government Structural Balance ($bn), Singapore, 2005–2010
Table 34: General Government Structural Balance ($bn), Singapore, Forecast, 2011–2020
Table 35: General Government Net Debt ($bn), Singapore, 2005–2010
Table 36: Major Industries, Singapore, Revenue Share (%), 2010
Table 37: Population (Millions), Singapore, 2005–2010
Table 38: Population (Millions), Singapore, Forecast, 2011–2020
Table 39: Age Groups, Singapore, Population Distribution (%), 2005–2010
Table 40: Age Groups, Singapore, Population Distribution (%), Forecast, 2011–2020
Table 41: Births (Per 1,000 Population), Singapore, 2005–2010
Table 42: Births (Per 1,000 Population), Singapore, Forecast, 2011–2020
Table 43: Mortality (Per 1,000 Population), Singapore, 2005–2010
Table 44: Major Causes of Mortality (‘000s), Singapore, 2010
Table 45: Major Causes of Male Mortality (‘000s), Singapore, 2010
Table 46: Major Causes of Female Mortality (‘000s), Singapore, 2010
Table 47: Maternal Mortality (Per 100,000 Live Births), Singapore, 2005–2010
Table 48: Children Less than Five Years of Age, Singapore, Mortality Rate (Per 1,000 Population), 2005-2010
Table 49: Immunization Rate (%), Singapore, 2005–2010
Table 50: Gender Ratio (M/F), Singapore, 2005–2010
Table 51: Gender Ratio (M/F), Singapore, Forecast, 2011–2020
Table 52: Life Expectancy at Birth (Years), Singapore, 2005–2010
Table 53: Life Expectancy at Birth (Years), Singapore, Forecast, 2011–2020
Table 54: Literacy Rate (%), Singapore, 2010
Table 55: Students at all Levels (‘000s), Singapore, 2005–2010
Table 56: Students at all Levels (‘000s), Singapore, Forecast, 2011–2020
Table 57: Levels of Education, Singapore, Students Share (%), 2010
Table 58: Employment Status (‘000s), Singapore, 2005–2010
Table 59: Employees, Singapore, Segment Share (%), 2010
Table 60: Unemployment Rate (%), Singapore, 2005–2010
Table 61: Major Diseases, Inpatients (%), Singapore, 2007–2009
Table 62: Major Diseases, Singapore, DALY (Per 100,000 Population), 2007
Table 63: Hospitals, Singapore, 2005–2010
Table 64: Hospitals, Singapore, Forecast, 2011–2020
Table 65: Public and Private Hospitals, Singapore, Share (%), 2005–2010
Table 66: Public and Private Hospitals, Singapore, Forecast, 2011–2020
Table 67: Beds (Per 1,000 Population), Singapore, 2005–2010
Table 68: Beds (Per 1,000 Population), Singapore, Forecast, 2011–2020
Table 69: Beds by Type of Hospital, Singapore, 2005–2010
Table 70: Physicians (Per 1,000 Population), Singapore, 2005–2010
Table 71: PM10 (Micrograms Per Cubic Meter), Singapore, 2005–2010
Table 72: CO2 Emissions (‘000 Tons), Singapore, 2005–2010
Table 73: CO2 Emissions (‘000 Tons), Singapore, Forecast, 2011–2020
Table 74: Organic Water Pollutants (Metric Tons), Singapore, 2005–2010
Table 75: Recycling Rate (%), Singapore, 2005–2010
Table 76: Disposable Waste (Million Tons), Singapore, 2005–2010
Table 77: Healthcare Personnel (%), Singapore, 2010
Table 78: Healthcare Personnel, Singapore, 2005–2010
Table 79: Healthcare Expenditure (% of the GDP), Singapore, 2005–2010
Table 80: Healthcare Expenditure (% of the GDP), Singapore, Forecast, 2011–2020
Table 81: Healthcare Expenditure, Singapore, Share of Major Components (%), 2010
Table 82: Healthcare Expenditure, Singapore, Public-Private Share (%), 2005–2010
Table 83: R&D Expenditure ($bn), Singapore, 2005–2010
Table 84: R&D Expenditure ($bn), Singapore, Forecast, 2011–2020
Table 85: Public and Private R&D Expenditure, Singapore, Share (%), 2005–2010
Table 86: Major Healthcare Trade Fairs, Singapore

1.2 List of Figures
Figure 1: Pharmaceutical Market ($m), Singapore, 2005–2011
Figure 2: Pharmaceutical Market ($m), Singapore, Forecast, 2011–2020
Figure 3: Distribution Channels, Singapore, 2011
Figure 4: Major Pharmaceutical Companies, Singapore, Revenue ($m), 2010
Figure 5: Drivers and Barriers, Healthcare Market, Singapore, 2011
Figure 6: Evolution of the Healthcare Insurance System, Singapore, 1984–2007
Figure 7: Healthcare Spending, Singapore, Patient Share (%), 2005–2010
Figure 8: Structure of the MOH, Singapore, 2011
Figure 9: Structure of the HSA, Singapore, 2011
Figure 10: New Drug Application Types, Singapore, 2011
Figure 11: New Drug Approval Process, Singapore, 2011
Figure 12: Licensing Process for Manufacturing, Singapore, 2011
Figure 13: Licensing Process for Import/Export, Singapore, 2011
Figure 14: Patent Approval Process, Singapore, 2011
Figure 15: Overseas Patent Approval Process, Singapore, 2011
Figure 16: Trademark Approval Process, Singapore, 2011
Figure 17: Designs Approval Process, Singapore, 2011
Figure 18: Clinical Trial Certificates, Singapore, 2005–2010
Figure 19: Clinical Trials by Therapeutic Areas (%), Singapore, 2010
Figure 20: Clinical Trial Regulation Process, Singapore, 2011
Figure 21: Pharmacy Regulations, Singapore, 2011
Figure 22: GDP Per Capita ($), Singapore, 2005–2010
Figure 23: GDP Per Capita ($), Singapore, Forecast, 2011–2020
Figure 24: GDP, Singapore, Annual Growth (%), 2005–2010
Figure 25: GDP, Singapore, Annual Growth (%), Forecast, 2011–2020
Figure 26: GNI Per Capita ($), Singapore, 2005–2010
Figure 27: Average Consumer Price Index, Singapore, 2005–2010
Figure 28: Average Consumer Price Index, Singapore, Forecast, 2011–2020
Figure 29: Average Consumer Price, Singapore, Annual Change (%), 2005–2010
Figure 30: Average Consumer Price, Singapore, Annual Change (%), Forecast, 2011–2020
Figure 31: Currency Exchange Rate (SGD/$), Singapore, 2005–2010
Figure 32: Foreign Direct Investment ($bn), Singapore, 2005–2010
Figure 33: Foreign Exchange Reserves ($bn), Singapore, 2005–2010
Figure 34: Trade Balance ($bn), Singapore, 2005–2010
Figure 35: Imports of Goods and Services ($bn), Singapore, 2005–2010
Figure 36: Exports of Goods and Services ($bn), Singapore, 2005–2010
Figure 37: General Government Structural Balance ($bn), Singapore, 2005–2010
Figure 38: General Government Structural Balance ($bn), Singapore, Forecast, 2011–2020
Figure 39: General Government Net Debt ($bn), Singapore, 2005–2010
Figure 40: Major Industries, Singapore, Revenue Share (%), 2010
Figure 41: Population (Millions), Singapore, 2005–2010
Figure 42: Population (Millions), Singapore, Forecast, 2011–2020
Figure 43: Age Groups, Singapore, Population Distribution (%), 2005–2010
Figure 44: Age Groups, Singapore, Population Distribution (%), Forecast, 2011–2020
Figure 45: Births (Per 1,000 Population), Singapore, 2005–2010
Figure 46: Births (Per 1,000 Population), Singapore, Forecast, 2011–2020
Figure 47: Mortality (Per 1,000 Population), Singapore, 2005–2010
Figure 48: Major Causes of Mortality (‘000s), Singapore, 2010
Figure 49: Major Causes of Male Mortality (‘000s), Singapore, 2010
Figure 50: Major Causes of Female Mortality (‘000s), Singapore, 2010
Figure 51: Maternal Mortality (Per 100,000 Live Births), Singapore, 2005–2010
Figure 52: Children Less than Five Years of Age, Singapore, Mortality Rate (Per 1,000 Population), 2005-2010
Figure 53: Immunization Rate (%), Singapore, 2005–2010
Figure 54: Gender Ratio (M/F), Singapore, 2005–2010
Figure 55: Gender Ratio (M/F), Singapore, Forecast, 2011–2020
Figure 56: Life Expectancy at Birth (Years), Singapore, 2005–2010
Figure 57: Life Expectancy at Birth (Years), Singapore, Forecast, 2011–2020
Figure 58: Literacy Rate (%), Singapore, 2010
Figure 59: Students at all Levels (‘000s), Singapore, 2005–2010
Figure 60: Students at all Levels (‘000s), Singapore, Forecast, 2011–2020
Figure 61: Levels of Education, Singapore, Students Share (%), 2010
Figure 62: Employment Status (‘000s), Singapore, 2005–2010
Figure 63: Employees, Singapore, Segment Share (%), 2010
Figure 64: Unemployment Rate (%), Singapore, 2005–2010
Figure 65: Major Diseases, Inpatients (%), Singapore, 2007–2009
Figure 66: Major Diseases, Singapore, DALY (Per 100,000 Population), 2007
Figure 67: Hospitals, Singapore, 2005–2010
Figure 68: Hospitals, Singapore, Forecast, 2011–2020
Figure 69: Public and Private Hospitals, Singapore, Share (%), 2005–2010
Figure 70: Public and Private Hospitals, Singapore, Forecast, 2011–2020
Figure 71: Beds (Per 1,000 Population), Singapore, 2005–2010
Figure 72: Beds (Per 1,000 Population), Singapore, Forecast, 2011–2020
Figure 73: Beds by Type of Hospital, Singapore, 2005–2010
Figure 74: Physicians (Per 1,000 Population), Singapore, 2005–2010
Figure 75: PM10 (Micrograms Per Cubic Meter), Singapore, 2005–2010
Figure 76: CO2 Emissions (‘000 Tons), Singapore, 2005–2010
Figure 77: CO2 Emissions (‘000 Tons), Singapore, Forecast, 2011–2020
Figure 78: Organic Water Pollutants (Metric Tons), Singapore, 2005–2010
Figure 79: Recycling Rate (%), Singapore, 2005–2010
Figure 80: Disposable Waste (Million Tons), Singapore, 2005–2010
Figure 81: Healthcare Personnel (%), Singapore, 2010
Figure 82: Healthcare Personnel, Singapore, 2005–2010
Figure 83: Healthcare Expenditure (% of the GDP), Singapore, 2005–2010
Figure 84: Healthcare Expenditure (% of the GDP), Singapore, Forecast, 2011–2020
Figure 85: Healthcare Expenditure, Singapore, Share of Major Components (%), 2010
Figure 86: Healthcare Expenditure, Singapore, Public-Private Share (%), 2005–2010
Figure 87: R&D Expenditure ($bn), Singapore, 2005–2010
Figure 88: R&D Expenditure ($bn), Singapore, Forecast, 2011–2020
Figure 89: Public and Private R&D Expenditure, Singapore, Share (%), 2005–2010
Figure 90: Opportunities and Challenges, Healthcare Market, Singapore, 2011

Customers who bought this item also bought

• Singapore Medical Tourism Industry Outlook to 2015
• HNWI in Singapore Wealth Management Industry – Trends, Analysis and Forecast (2010-2015)
• Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
• Asia Medical Tourism Industry Outlook to 2015 - The Destination for Foreign Patients
• Singapore Pharmaceuticals and Healthcare Report Q1 2012
• Healthcare Providers in Singapore
• Singapore Healthcare Industry 2H12
• Multi-client Study: Opportunities Assessment for Hepatitis C Therapeutics Market in Singapore
• Singapore Pharmaceuticals and Healthcare Report Q1 2013
• Singapore Pharmaceuticals and Healthcare Report Q3 2011